HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

H E Kaiser Selected Research

Alkaline Phosphatase

11/2002Expression of proline-directed protein kinase, (p34cdc2/p58cyclin A), a novel cell proliferation marker in childhood brain tumors.
5/2001Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas.
3/2001Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung.
1/2001Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
1/2001Immunocytochemical detection of the expression of members of the matrix metalloproteinase family in adenocarcinomas of the pancreas.
1/2001Immunocytochemical detection of matrix metalloproteinase expression in prostate cancer.
11/2000Immunocytochemical detection of MMP-3 and -10 expression in hepatocellular carcinomas.
9/2000Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.
9/2000Matrix metalloproteinase expression in childhood astrocytomas.
9/2000Serum levels of immunoreactive bone sialoprotein in osteoporosis: positive relations to established biochemical parameters of bone turnover.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


H E Kaiser Research Topics

Disease

24Neoplasms (Cancer)
09/2007 - 01/2000
11Neoplasm Metastasis (Metastasis)
05/2001 - 07/2000
6Primitive Neuroectodermal Tumors (PNET)
11/2002 - 05/2000
4Brain Neoplasms (Brain Tumor)
11/2002 - 05/2000
4Medulloblastoma
07/2001 - 05/2000
4Carcinoma (Carcinomatosis)
05/2001 - 07/2000
3Astrocytoma (Pilocytic Astrocytoma)
07/2001 - 05/2000
3Adenocarcinoma
03/2001 - 01/2000
3Melanoma (Melanoma, Malignant)
01/2001 - 05/2000
2Infection
11/2000 - 01/2000
2Colorectal Neoplasms (Colorectal Cancer)
09/2000 - 01/2000
2Inflammation
09/2000 - 09/2000
2Osteoporosis
09/2000 - 09/2000
1Osteosarcoma (Osteogenic Sarcoma)
09/2007
1Leiomyosarcoma
09/2007
1Sarcoma (Soft Tissue Sarcoma)
09/2007
1Leiomyoma (Uterine Fibroids)
09/2007
1Soft Tissue Neoplasms
09/2007
1Liposarcoma
09/2007
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
09/2007
1Endometrial Neoplasms (Endometrial Cancer)
01/2007
1Choroid Plexus Neoplasms (Choroid Plexus Tumor)
11/2002
1Fever (Fevers)
11/2000
1Shock
11/2000
1Neoplastic Cell Transformation
11/2000
1Necrosis
11/2000
1Hepatocellular Carcinoma (Hepatoma)
11/2000
1Vitamin D Deficiency
09/2000
1Glioblastoma (Glioblastoma Multiforme)
09/2000
1Bone Diseases (Bone Disease)
09/2000
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2000
1Hypogonadism (Hypergonadotropic Hypogonadism)
09/2000
1Lung Neoplasms (Lung Cancer)
09/2000
1Residual Neoplasm
07/2000
1Anxiety Disorders (Anxiety Disorder)
05/2000
1Autoimmune Diseases (Autoimmune Disease)
04/2000

Drug/Important Bio-Agent (IBA)

13Alkaline PhosphataseIBA
11/2002 - 05/2000
10Matrix MetalloproteinasesIBA
05/2001 - 09/2000
9AntigensIBA
11/2002 - 02/2000
5oncofetal antigensIBA
09/2000 - 05/2000
4Monoclonal AntibodiesIBA
07/2001 - 01/2000
3AntibodiesIBA
11/2002 - 02/2000
3Proteins (Proteins, Gene)IBA
11/2002 - 05/2000
3HormonesIBA
11/2000 - 01/2000
3EnzymesIBA
09/2000 - 09/2000
2ParaffinIBA
11/2002 - 05/2000
2Formaldehyde (Formol)FDA Link
11/2002 - 05/2000
2StreptavidinIBA
11/2002 - 05/2001
2Biotin (Vitamin H)FDA Link
11/2002 - 05/2001
2Surface Antigens (Surface Antigen)IBA
07/2001 - 05/2000
2CD45 Antigens (CD45 Antigen)IBA
07/2001 - 05/2000
2CytotoxinsIBA
11/2000 - 01/2000
2VaccinesIBA
07/2000 - 02/2000
2CytokinesIBA
01/2000 - 01/2000
1Cyclin D3IBA
09/2007
1Cyclin D1IBA
09/2007
1CyclinsIBA
09/2007
1Cell Cycle ProteinsIBA
09/2007
1Antineoplastic Agents (Antineoplastics)IBA
01/2007
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2007
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2002
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
11/2002
1Proline-Directed Protein KinasesIBA
11/2002
1Differentiation AntigensIBA
07/2001
1CalciumIBA
11/2000
1Cytostatic AgentsIBA
11/2000
1Cell Surface ReceptorsIBA
11/2000
1Protons (Proton)IBA
11/2000
1Calcimycin (A23187)IBA
11/2000
1Dactinomycin (Ac-De)FDA LinkGeneric
11/2000
1IonophoresIBA
11/2000
1arseniteIBA
11/2000
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2000
1Adenosine Triphosphate (ATP)IBA
11/2000
1P-GlycoproteinIBA
11/2000
1Biogenic Amines (Biogenic Amine)IBA
11/2000
1RibonucleoproteinsIBA
11/2000
1Telomerase (Telomerase Reverse Transcriptase)IBA
11/2000
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2000
1ruberythric acid (AlP)IBA
09/2000
1Integrin-Binding SialoproteinIBA
09/2000
1procollagen type I carboxy terminal peptide (PICP)IBA
09/2000
1hydroxide ionIBA
09/2000
1Estradiol (Estrace)FDA LinkGeneric
09/2000
1Proliferating Cell Nuclear Antigen (PCNA)IBA
09/2000
1Biological Markers (Surrogate Marker)IBA
09/2000
1Matrix Metalloproteinase 13IBA
09/2000
1OsteocalcinIBA
09/2000
1Testosterone (Sustanon)FDA Link
09/2000
1ZincIBA
09/2000
1SteroidsIBA
09/2000
1Collagen Type I (Type I Collagen)IBA
09/2000
1Cancer VaccinesIBA
07/2000
1ThymosinIBA
04/2000
1Thymus HormonesIBA
04/2000
1Immunologic Factors (Immunomodulators)IBA
04/2000
1Radioisotopes (Radionuclides)IBA
02/2000

Therapy/Procedure

6Immunotherapy
11/2000 - 02/2000
4Drug Therapy (Chemotherapy)
07/2000 - 02/2000
2Chemoprevention
01/2007 - 11/2002